{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T14:11:08Z","timestamp":1784470268487,"version":"3.55.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.3892\/etm.2015.2349","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T11:21:55Z","timestamp":1426159315000},"page":"1915-1920","source":"Crossref","is-referenced-by-count":13,"title":["Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review"],"prefix":"10.3892","volume":"9","author":[{"given":"JOHN T.","family":"DENNY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW T.","family":"BURR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRED","family":"BALZER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAMES T.","family":"TSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JULIA E.","family":"DENNY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DARRICK","family":"CHYU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,3,12]]},"reference":[{"key":"key20180108130034_b1-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1182\/blood-2013-02-485623","article-title":"Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy","volume":"121","author":"Teachey","year":"2013","journal-title":"Blood"},{"key":"key20180108130034_b2-etm-0-0-2349","unstructured":"Sanofi Canada: Thymoglobulin\u00ae (Anti-thymocyte globulin [rabbit]) product monographhttp:\/\/products.sanofi.ca\/en\/thymoglobulin.pdfJan252015"},{"key":"key20180108130034_b3-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4161\/mabs.2.2.11159","article-title":"Antibody immunosuppressive therapy in solid-organ transplant: Part I","volume":"2","author":"Mahmud","year":"2010","journal-title":"MAbs"},{"key":"key20180108130034_b4-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejcts.2005.07.011","article-title":"Vasoplegic syndrome - the role of methylene blue","volume":"28","author":"Shanmugam","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20180108130034_b5-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"key20180108130034_b6-etm-0-0-2349","first-page":"306","article-title":"Methylene blue administration in severe systemic inflammatory response syndrome (SIRS) after thoracic surgery","volume":"8","author":"Friedrich","year":"2002","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"key20180108130034_b7-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2174\/138955708784223477","article-title":"Methylene blue and vasoplegia: who, when, and how?","volume":"8","author":"Stawicki","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"key20180108130034_b8-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1053-2498(99)00038-8","article-title":"Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation","volume":"18","author":"Argenziano","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"key20180108130034_b9-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0003-4975(96)00225-1","article-title":"SIRS - the systemic inflammatory response syndrome after cardiac operations","volume":"61","author":"Taylor","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"key20180108130034_b10-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/0003-4975(92)90113-I","article-title":"Release of vasoactive substances during cardiopulmonary bypass","volume":"54","author":"Downing","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"key20180108130034_b11-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.jvca.2008.11.016","article-title":"The use of methylene blue for vasodilatory shock in a pediatric lung transplant patient","volume":"23","author":"Flynn","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"key20180108130034_b12-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"key20180108130034_b13-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.179.1.71","article-title":"Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway","volume":"179","author":"Beasley","year":"1994","journal-title":"J Exp Med"},{"key":"key20180108130034_b14-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function","volume":"71","author":"Mekontso-Dessap","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"Suppl","key":"key20180108130034_b15-etm-0-0-2349","first-page":"S149","article-title":"Vasopressin deficiency in the syndrome of irreversible shock","volume":"54","author":"Robin","year":"2003","journal-title":"J Trauma"},{"key":"key20180108130034_b16-etm-0-0-2349","first-page":"277","article-title":"Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response","volume":"63","author":"Boyle","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"key20180108130034_b17-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/0885066606290671","article-title":"Use of methylene blue in sepsis: A systematic review","volume":"21","author":"Kwok","year":"2006","journal-title":"J Intensive Care Med"},{"key":"key20180108130034_b18-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI25426","article-title":"Anaphylactic shock depends on PI3K and eNOS-derived NO","volume":"116","author":"Cauwels","year":"2006","journal-title":"J Clin Invest"},{"key":"key20180108130034_b19-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1152\/physrev.2000.80.4.1669","article-title":"Role of platelet-activating factor in cardiovascular pathophysiology","volume":"80","author":"Montrucchio","year":"2000","journal-title":"Physiol Rev"},{"key":"key20180108130034_b20-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinte.161.1.15","article-title":"Anaphylaxis in the United States: an investigation into its epidemiology","volume":"161","author":"Neugut","year":"2001","journal-title":"Arch Intern Med"},{"key":"key20180108130034_b21-etm-0-0-2349","first-page":"619","article-title":"Vasoplegic syndrome after open heart surgery","volume":"39","author":"Gomes","year":"1998","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"key20180108130034_b22-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1992.tb09021.x","article-title":"Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium","volume":"105","author":"Schulz","year":"1992","journal-title":"Br J Pharmacol"},{"key":"key20180108130034_b23-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/0003-4975(96)00055-0","article-title":"Systemic inflammatory response syndrome after cardiac operations","volume":"61","author":"Cremer","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"key20180108130034_b24-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.all.0000174158.78626.35","article-title":"Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis","volume":"5","author":"Brown","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"key20180108130034_b25-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1067\/mai.2002.126811","article-title":"Anaphylaxis: a review of causes and mechanisms","volume":"110","author":"Kemp","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"key20180108130034_b26-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF03021822","article-title":"Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway","volume":"53","author":"Takakura","year":"2006","journal-title":"Can J Anaesth"},{"key":"key20180108130034_b27-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1378\/chest.122.3.1061","article-title":"Catastrophic cardiovascular adverse reactions to protamine are nitric oxide\/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice?","volume":"122","author":"Viaro","year":"2002","journal-title":"Chest"},{"key":"key20180108130034_b28-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00003246-200210000-00015","article-title":"Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?","volume":"30","author":"Donati","year":"2002","journal-title":"Crit Care Med"},{"key":"key20180108130034_b29-etm-0-0-2349","first-page":"267","article-title":"Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide","volume-title":"Proc Natl Acad Sci USA","author":"Thiemermann"},{"key":"key20180108130034_b30-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/16.7.1436","article-title":"Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension","volume":"16","author":"Peer","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108130034_b31-etm-0-0-2349","first-page":"24S","article-title":"Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression","volume-title":"Transplant Proc","author":"Guttmann"},{"key":"key20180108130034_b32-etm-0-0-2349","first-page":"16","article-title":"General aspects of cytokine-release syndrome: timing and incidence of symptoms","volume-title":"Transplant Proc","author":"Jeyarajah"},{"key":"key20180108130034_b33-etm-0-0-2349","first-page":"60","article-title":"Cytokine-release syndrome: general risk-factor modification - preparation of high-risk patients for use of OKT3","volume-title":"Transplant Proc","author":"Radhakrishnan"},{"issue":"Suppl","key":"key20180108130034_b34-etm-0-0-2349","first-page":"II182","article-title":"Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery","volume":"100","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"key20180108130034_b35-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00134-009-1630-1","article-title":"Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial","volume":"36","author":"Torgersen","year":"2010","journal-title":"Intensive Care Med"},{"key":"key20180108130034_b36-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Critical Care Med"},{"key":"key20180108130034_b37-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.297.15.joc70035","article-title":"TRIUMPH Investigators: Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial","volume":"297","author":"Alexander","year":"2007","journal-title":"JAMA"},{"key":"key20180108130034_b38-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jtcvs.2012.07.030","article-title":"The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature","volume":"144","author":"Grubb","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180108130034_b39-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0971-9784.97977","article-title":"Clinical review: management of weaning from cardiopulmonary bypass after cardiac surgery","volume":"15","author":"Licker","year":"2012","journal-title":"Ann Card Anaesth"},{"key":"key20180108130034_b40-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/TA.0b013e3181bbfaac","article-title":"DCLHb Traumatic Hemorrhagic Shock Study Group; European HOST Investigators: Diaspirin cross-linked hemoglobin infusion did not influence base deficit and lactic acid levels in two clinical trials of traumatic hemorrhagic shock patient resuscitation","volume":"68","author":"Sloan","year":"2010","journal-title":"J Trauma"},{"key":"key20180108130034_b41-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0022-5223(02)73284-4","article-title":"Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?","volume":"125","author":"Leyh","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180108130034_b42-etm-0-0-2349","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: current concepts and management","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2349\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:51:36Z","timestamp":1515451896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,12]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,3,12]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.3892\/etm.2015.2349"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2349","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,12]]}}}